A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase Study

Clinical trial NCT01702350 · TERMINATED

Trial details

NCT number: NCT01702350
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Community-acquired Infection

Start date: 2011-10-21
Primary completion: 2011-12-08
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.